BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27914767)

  • 21. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
    Qiu W; Schönleben F; Li X; Su GH
    Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
    Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
    Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression and prognostic role of selected genes in colorectal cancer patients.
    Pitule P; Vycital O; Bruha J; Novak P; Hosek P; Treska V; Hlavata I; Soucek P; Kralickova M; Liska V
    Anticancer Res; 2013 Nov; 33(11):4855-65. PubMed ID: 24222123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer.
    Leng A; Liu T; He Y; Li Q; Zhang G
    Exp Mol Pathol; 2009 Aug; 87(1):48-53. PubMed ID: 19341727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
    Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
    Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer.
    Losi L; Bouzourene H; Benhattar J
    Oncol Rep; 2007 May; 17(5):1095-9. PubMed ID: 17390050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
    Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
    J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of microRNA-31 expression in early colorectal cancer.
    Tateishi Y; Okudela K; Mitsui H; Umeda S; Suzuki T; Kojima Y; Watanabe K; Kawano N; Endo I; Ohashi K
    Pathol Int; 2015 Oct; 65(10):513-8. PubMed ID: 26173758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the p65 gene in patients with colorectal cancer: comparison with some histological typing, grading and clinical staging.
    Balcerczak M; Balcerczak E; Pasz-Walczak G; Kordek R; Mirowski M
    Eur J Surg Oncol; 2004 Apr; 30(3):266-70. PubMed ID: 15028307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.
    Ijichi H; Ikenoue T; Kato N; Mitsuno Y; Togo G; Kato J; Kanai F; Shiratori Y; Omata M
    Biochem Biophys Res Commun; 2001 Nov; 289(2):350-7. PubMed ID: 11716479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour-promoting role of SOCS1 in colorectal cancer cells.
    Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
    Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
    Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A
    Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
    Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
    Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging.
    Balcerczak M; Pasz-Walczak G; Balcerczak E; Wojtylak M; Kordek R; Mirowski M
    Pathol Res Pract; 2003; 199(10):641-6. PubMed ID: 14666966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.